We used neural networks in ~3,000 sleep recordings from over 10 locations to automate sleep stage scoring, producing a probability distribution called an hypnodensity graph. Accuracy was validated in 70 subjects scored by six technicians (gold standard). Our best model performed better than any individual scorer, reaching an accuracy of 0.87 (and 0.95 when predictions are weighed by scorer agreement). It also scores sleep stages down to 5-second instead of the conventional 30-second scoring-epochs. Accuracy did not vary by sleep disorder except for narcolepsy, suggesting scoring difficulties by machine and/or humans. A narcolepsy biomarker was extracted and validated in 105 type-1 narcoleptics versus 331 controls producing a specificity of 0.96 and a sensitivity of 0.91. Similar performances were obtained against a high pretest probability sample of type-2 narcolepsy and idiopathic hypersomnia patients. Addition of HLA-DQB1*06:02 increased specificity to 0.99. Our method streamlines scoring and diagnoses narcolepsy accurately.
Introduction
Sleep disorders and sleep dysregulation impact over 100 million Americans, contributing to significant medical consequences including cardiovascular (arrhythmia, hypertension, stroke), metabolic (diabetes, obesity) and psychiatric disorders (depression, irritability, addictive behaviors), to name only a few. Sleep deprivation impairs performance, judgment, mood, and is a major preventable contributor to accidents Among these pathologies, type-1 narcolepsy is unique as the only sleep disorder with a known, discrete pathophysiology -an autoimmune mediated destruction of hypocretin neurons in the hypothalamus 3, 4 . Narcolepsy is a lifelong condition affecting approximately 0.05% of the population 5 . Unique to narcolepsy is the extremely strong (97% versus 25%) association with a genetic marker, HLA-DQB1*06:02 6, 7 , and a well characterized set of sleep disturbances that include short sleep latency, rapid transitions into REM sleep and poor nocturnal sleep consolidation 5 . The pathology also includes episodes of "sleep/wake dissociation" where the patient is half awake and half in REM sleep, for example experiencing REM sleep muscle paralysis while awake (sleep paralysis, cataplexy) or dreaming while awake (hypnagogic hallucinations) 5 .
Sleep disorders are generally assessed at sleep clinics by performing sleep analysis using nocturnal polysomnography (PSG), a recording comprised of multiple digital signals which include electroencephalography (EEG), electrooculography (EOG), chin and leg electromyography (EMG), electrocardiography (ECG), breathing effort, oxygen saturation, and airflow 8 . When sleep is analyzed in PSGs, it is divided into discrete stages: wake, non REM (NREM) sleep stage 1 (N1), 2 (N2) and 3 (N3), and REM. Each stage is characterized by different criteria, as defined by consensus rules published in the American Academy of Sleep Medicine (AASM) Scoring Manual 8, 9 . N1 (sleep onset) is characterized by slowing of the EEG, disappearance of occipital alpha waves, decreased EMG and slow rolling eye movements, while N2 is associated with spindles and K-complexes. N3 is characterized by a dominance of slow, high amplitude waves (>30%), while REM sleep is associated with low voltage, desynchronized EEG with occasional saw tooth waves, low muscle tone and REMs. PSG analysis is typically done by certified technicians who, through visual inspection on a standardized screen, assign a sleep stage to each 30 second segment of the full recording. Although there is progression from N1 to N3 then to REM during the night, a process that repeats approximately every 90 minutes (the sleep cycle), each stage is associated with physiological changes that can be meaningful to the assessment of sleep disorders such as obstructive sleep apnea. For example, the abnormal breathing events that occur with obstructive sleep apnea are generally less severe in N3 versus N2 because central control of breathing changes, and they are more severe in REM sleep, due to upper airway muscle weakness 10 . The differentiation of sleep stages is also particularly important for the diagnosis of narcolepsy, a condition currently assessed by a PSG followed by a Multiple Sleep Latency Test (MSLT), a test where patients are asked to nap 4-5 times for 20 minutes every 2 hours during the daytime and sleep latency and the presence of REM sleep is noted 11, 12 . A mean sleep latency (MSL) less than 8 minutes (indicative of sleepiness) and the presence of at least 2 sleep onset REM periods (SOREMPs) during the MSLT or 1 SOREM plus a REM latency ≤15 minutes during PSG is highly diagnostic for narcolepsy. In a recent large study of the MSLT 13 , specificity and sensitivity for type-1 narcoleptics were, respectively, 98.6% and 92.9% in comparing 516 type-1 narcolepsy versus 516 controls and 71.2% and 93.4% in comparing 122 type-1 narcolepsy cases versus other 132 hypersomnia cases (high pretest probability cohort). Similar sensitivity (75-90%) and specificity (90-98%) have been reported by others in large samples of hypersomnia cases versus type-1 narcolepsy [14] [15] [16] [17] [18] [19] .
Manual inspection of sleep recordings has many problems. It is time consuming, expensive, inconsistent, subjective, and must be done offline. In one study, Rosenberg et al. 20 found interscorer reliability for sleep stage scoring to be 82.6% on average, a result consistently found by others [21] [22] [23] [24] . N1 and N3 in particular have agreements as low as 63% and 67%, placing constraints on their usefulness 20 . In this study, we explored whether machine learning could produce a fast, inexpensive, objective, and reproducible alternative to manual sleep stage scoring. In recent years, similar problems, such as labeling images, understanding speech and translating language, have seen advancement to the point of outperforming humans 25, 26 . This technology, called deep learning, refers to neural network models, often with a very large number of parameters and layers. In this implementation of deep learning, we introduce the hypnodensity graph-a hypnogram that does not enforce a single sleep stage label, but rather a membership function to each of the sleep stages, allowing more information about sleep trends to be conveyed, something that is only possible in non-human scoring.
Using this concept, we next applied deep learning derived hypnodensitity features to the diagnosis of type-1 narcolepsy, showing that an analysis of a single PSG night can perform as well as the MSLT gold standard, a two day procedure.
Methods

Datasets
The success of machine learning depends on the size and quality of the data on which the model is trained and evaluated 27, 28 . We used a large dataset comprised of several thousand sleep studies to train, validate and test/replicate our models. To ensure significant heterogeneity, data came from 8 different cohorts recorded at 10 sleep centers across 3 continents: The Stanford Sleep Cohort (SSC), the Wisconsin Sleep Cohort (WSC), an inter-scorer reliability cohort (IS-RC), the Jazz clinical trial sample (JCTS), the Korean Hypersomnia sample (KHS), the Austrian Hypersomnia Sample (AHS), the Italian Hypersomnia Sample (IHS) and the Danish Hypersomnia sample (DHS). Technicians trained in sleep scoring manually labeled all sleep studies. Figure 1A , 1B and 1C summarize the overall design of the study for sleep stage scoring and narcolepsy biomarker development. Supplementary Table 1 provides a summary of the size of each cohort and how it was used. In the narcolepsy biomarker aspect of the study, PSGs from type-1 narcolepsy and other patients were split across datasets to ensure heterogeneity in both the training and testing dataset. For this analysis, a few recordings with poor quality sleep studies, i.e. missing critical channels, with additional sensors or with a too short sleep duration (≤ 2 hours) were excluded. A brief description of each dataset can be found below.
Population-based Wisconsin Sleep Cohort (WSC)
This cohort is a longitudinal study of state agency employees aged 37 -82 years from Wisconsin, and approximates a population-based sample (see Supplementary Table 1 for age at study) and are generally more overweight 29 . The study is ongoing, and dates to 1988. 2167 PSGs in 1086 subjects were used for training while 286 randomly selected PSGs were used for validation testing of the sleep stage-scoring algorithm and narcolepsy biomarker training. Approximately 25% of the population have an Apnea Hypopnea Index (AHI) above 15/hour and 40% have a Periodic Leg Movement Index (PLMI) above 15/hr. A detailed description of the sample can be found in Young 29 and Moore et al. 30 The sample does not contain any type-1 narcolepsy patients, and the three subjects with possible type-1 narcolepsy were removed 31 .
Patient-based Stanford Sleep Cohort (SSC)
PSGs from this cohort were recorded at the Stanford Sleep Clinic dating back to 1999, and represent sleep disorder patients aged 18-91 visiting the clinic (see Supplementary Table 1 for age at study). The cohort contains thousands of PSG recordings, but for this study we used 894 diagnostic (no positive airway pressure(PAP)) recordings in independent patients that have been used in prior studies 30 . This subset contains patients with a range of different diagnoses including: sleep disordered breathing (607), insomnia (141), REM sleep behavior disorder (4), restless legs syndrome (23), type-1 narcolepsy (25), delayed sleep phase syndrome (14) , and other conditions (39) . Description of the subsample can be found in Andlauer et al. 13 and Moore et al. 30 Approximately 30% of subjects have an AHI above 15/hour, or a PLMI above 15/hour. 617 randomly selected subjects were used for training the neural networks while 277 randomly selected PSGs were kept for validation testing of the sleep stage scoring algorithm. These 277 subjects were also used for training the narcolepsy biomarker algorithm. The sample contains PSGs of 25 independent untreated subjects with Type-1 narcolepsy (12 with low CSF hypocretin-1, the others with clear cataplexy). 26 subjects were removed from the study -4 due to a poor data quality, and the rest because of medication use.
Patient-based Korean Hypersomnia Cohort (KHC)
The Korean Hypersomnia Cohort is a high pretest probability sample for narcolepsy. It includes 160 patients with a primary complaint of excessive daytime sleepiness (see Supplementary Table  1 for age at study). These PSGs were used for testing the sleep scoring algorithm and for training the narcolepsy biomarker algorithm. No data was used for training the sleep-scoring algorithm.
Detailed description of the sample can be found in Hong et al. 32 and Andlauer et al. 13 The sample contains PSGs of 66 independent untreated subjects with type-1 narcolepsy and clear cataplexy. Two subjects were removed from the narcolepsy biomarker study because of poor data quality.
Patient-based Austrian Hypersomnia Cohort (AHC)
Patients in this cohort were examined at the Innsbruck Medical University in Austria as described in Frauscher et al. 37 . The AHC contains 118 PSGs in 86 high pretest probability patients for narcolepsy (see supplementary Table 1 for details). 42 patients (81 studies) are clear Type-1 narcolepsy with cataplexy cases, with all but 3 having a positive MSLT (these three subjects had a mean sleep latency (MSL)>8 minutes but multiple sleep onset REM periods (SOREMPs)). The rest of the sample has idiopathic hypersomnia and type-2 narcolepsy. Four patients have an AHI>15/hour and 25 had a PLMI>15/hour. As almost all subjects had two sleep recordings, two subset test replication samples were developed using independent sleep studies in the 2 subcohorts.
. The sample does not contain any Type-1 narcolepsy patients.
The Jazz Clinical Trial Sample (JCTS)
This sample includes seven baseline sleep PSGs from five sites taken from a clinical trial study of sodium oxybate in narcolepsy (SXB15 with 45 sites in Canada, USA, and Switzerland) conducted by Orphan Medical, now named Jazz Pharmaceuticals. The few patients included are those with clear and frequent cataplexy (a requirement of the trial) that had no stimulant or antidepressant treatment at baseline included 35, 36 .
Patient-based Italian Hypersomnia Cohort (IHC)
Patients in this high pretest probability cohort (see Supplementary table 1 for demographics) were examined at the IRCCS, Istituto delle Scienze Neurologiche ASL di Bologna in Italy as described in Pizza et al.
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. The IHC contains 70 type-1 narcoleptic patients (58% male, 29.5± 1.9 years old), with either documented low CSF hypocretin levels (59 cases, all but 2 HLA DQB1*06:02 positive), or clear cataplexy, positive MSLTs and HLA positivity (11 subjects). As non-type-1 narcolepsy cases with unexplained daytime somnolence, the cohort includes 77 other patients: 19 with idiopathic hypersomnia, 7 with type-2 narcolepsy and normal CSF hypocretin-1, 48 with a subjective complaint of excessive daytime sleepiness not confirmed by MSLT, and 3 with secondary hypersomnia.
Patient-based Danish Hypersomnia Cohort (DHC)
Patients in this cohort were examined at the Rigshospitalet, Glostrup in Denmark as described in Christensen et al 39 .
The DHC contains 79 PSGs in controls and patients (age 13-68, see supplementary Table 1 for details). Based on PSG, multiple sleep latency test and cerebrospinal fluid hypocretin-1 measures, the cohort includes healthy controls (19 subjects), patients with other sleep disorders and excessive daytime sleepiness (20 patients with CSF hypocretin-1 ≥ 110 pg/ml), narcolepsy type-2 (22 patients with CSF hypocretin-1 ≥ 110 pg/ml), and narcolepsy type-1 (28 patients with CSF hypocretin 1 ≤ 110 pg/ml).
American Academy of Sleep Medicine (AASM) sleep study
The AASM dataset is composed of a single control sleep study of 150 30 sec epochs that was scored by 5234±14 experienced sleep technologists for quality control purposes. Design of this data set is described in Rosenberg et al. 20 .
Data Labels, Scoring and Fuzzy Logic
Sleep-stages were scored by PSG-trained technicians using established scoring rules, as described in the AASM Scoring Manual 9 , (see http://www.aasmnet.org/scoringmanual/). In doing so, technicians assign each epoch with a discrete value. With a probabilistic model, like the one proposed in this study, a relationship is instead inferred to one of the stages is based on thousands of training examples labeled by many different scoring-technicians.
In this paper the probability distribution over each possible stage for each epoch will be referred to as a "hypnodensity graph", as seen in Figure 5a and 5b. This allows more information to be conveyed, since every epoch of sleep within the same stage is not identical. For comparison with the gold standard, however, a discrete value must be assigned from the model output as:
Where ( | ) is a vector with the estimated probabilities for each sleep stage in the i th segment, N is the number of segments an epoch is divided into, and y � the estimated label.
Sleep scoring technicians score sleep in 30 second epochs, based on what stage they assess is represented in the majority of the epoch -a relic of when such recordings were done on paper 40 . This means that half of the epoch could possibly not match the assigned label. This is evident in the fact that the label accuracy decreases near transitions 20 . One solution to this problem is to remove transitional regions to purify each class. However, this has the disadvantage of undersampling transitional stages, such as N1, and removes the context of quickly changing stages, as is found in a sudden arousal. It has been demonstrated that the negative effects of imperfect "noisy" labels may be mitigated if a large enough training dataset is incorporated and the model is robust to overfitting 41 . This also assumes that the noise is randomly distributed with an accurate mean -a bias cannot be cancelled out, regardless of the amount of training data. For these reasons, all data including those containing sleep transitions were included. Biases were evaluated by incorporating data from several different scoring experts, cohorts and types of subjects.
To ensure quick convergence, while also allowing for long-term dependencies in memory-based models, the data were broken up in 5 minute blocks and shuffled to minimize the shift in covariates during training caused by differences between subjects. To quantify the importance of segment sizes, both 5 second and 15 second segments were tested.
Data Selection and Pre-Processing
A full night PSG involves recording many different channels, some of which are not necessary for sleep scoring 29 . In this study, EEG -C3 or C4, and O1 or O2, chin EMG, and the left and right EOG channels were used. Poor electrode connections are common when performing a PSG analysis, and this leads to noisy recordings. To determine which EEG channel to use, the noise of each was quantified by dividing the EEG data in 5 minute segments, and extracting the Hjorth parameters 30 . These were then log-transformed, averaged, and compared with a previously established multivariate distribution of hjorth parameters, based on the WSC and SSC training data. The channel with lowest Mahalanobis distance 31 to this distribution was selected. Advantageously, log-transforming makes flat signals/disconnects as unlikely to be selected as noisy signals. To minimize heterogeneity across recordings, while also reducing the size of the data, all channels were down-sampled to 100 Hz. Additionally, all channels were filtered with a 5 th order two-direction IIR high-pass filter with fc=0.2 Hz and a 5 th order two-direction IIR low-pass filter with fc=49 Hz. All steps of the pre-processing are illustrated in figure 1A .
Convolutional (CNN) and recurrent (RNN) neural networks
A CNN is a supervised classification model in which a low-level input that is not optimized to the task at hand, such as an image, is transformed through a network of filters and sub-sampling layers. Each layer of filters produces a set of features from the previous layer, and as more layers are stacked, more complex features are generated. This network is coupled with a generalpurpose learning algorithm, resulting in features produced by the model reflecting properties of the data and the associated labels, rather than the imagination of the designer. This property places fewer constrictions on the model by allowing more flexibility, and hence the predictive power of the model will increase as more data is observed. This is facilitated by the large number of parameters in such a model, but may also necessitate a large amount of training data. Sleep stage scoring involves a classification of a discrete time-series, in which adjacent segments are correlated. Models that incorporate memory, may take advantage of this, and may lead to better overall performance by evening out fluctuations. Problematically, however, these fluctuations may be the defining trait or anomaly of some underlying pathology (such as narcolepsy, a pathology well known to involve abnormal sleep stages transitions), present in only a fraction of subjects, and perhaps none of the training data. To analyze the importance of this, models with and without memory were analyzed. Memory can be added to such a model by introducing recurrent connections in the final layers of the model. This turns the model into a recurrent neural network (RNN). In this study we use a standard LSTM architecture. Models without memory are referred to as feed-forward (FF) models. A more in depth explanation of CNNs can be found in LeCun et al.'s review article 32 .
Data input and transformations
Biophysical signals, such as those found in a PSG, inherently have a low signal to noise ratio, the degree of which varies between subjects, and hence learning robust features from these signals may be difficult. To circumvent this, two representations of the data minimizes these effects were selected. An example of each decomposition is shown in Figure 2a .
Octave decomposition: This representation maintains signal information, and enriches it by repeatedly removing the top half of the using a series of low-pass filters bandwidth (with cut off frequencies of 49, 25, 12.5, 6.25 and 3.125 Hz), yielding 5 new channels for each original channel. After filtration, each new channel is scaled to the 95 th percentile and log modulus transformed
The initial scaling places 95% of the data between -1 and 1, a range in which the log modulus is close to linear. Very large values, such as those found in particularly noisy areas, are attenuated greatly. Some recordings are noisy, making the 95 th percentile significantly higher than what the physiology reflects. Therefore, instead of the selecting the 95 th percentile from the entire recording, the recording is separated into 50% overlapping 90 minute segments, from which the 95 th percentile is extracted, and the mode is used as a scaling reference. In general, scaling and normalization is important to ensure quick convergence and generalization in neural networks 33 . The decomposition is done in the same way on every channel, resulting in 25 new channels in total.
Cross-correlation decomposition (CC): Using a cross-correlation function, underlying periodicities in the data are revealed while noise is attenuated. White noise is by definition uncorrelated; its autocorrelation function is zero everywhere except lag zero. It is this property that is utilized, even though noise cannot always be modeled as such. The cross-correlation is designed with a zeropadded version and an extended version of a signal, as demonstrated in supplementary figure 1. Designing the cross-correlation in this manner over a standard autocorrelation function serves two purposes: the slow frequencies are expressed better, since there is always full overlap between the two signals and the change in fluctuations over time within a segment is expressed, making the function reflect aspects of stationarity.
Frequency content with a time resolution may also be expressed using something like a spectrogram, however, one of the key properties of a CNN is the ability to detect distinct features anywhere in an input, given its property of equivariance 34 . A cross-correlation function reveals an underlying set of frequencies as an oscillation pattern, as opposed to a spectrogram, where frequencies are displayed streaks or spots in specific locations, corresponding to frequencies at specific times. The length and size of each cross-correlation reflects the expected frequency content and the limit of quasi-stationarity (i.e. how quickly the frequency content is expected to change). The EEG signal is quasi-stationary in signals with a length of up to 0.25 seconds 35 . The lowest expected meaningful frequencies are delta-waves, which have a lower bound of 0.5 Hz
36
. Hence, the transformation is made up of 2 second segments with 1.75 second overlaps.
The EOG signal reveals information about eye movements such as REMs, and to some extent EEG activity 8, 9 . The relative phase between the two channels is important to determine synchronized eye movements, and hence a cross-correlation of opposite channels is also included. The slowest eye-movements are several seconds long 8, 9 , so a segment length of 4 seconds was selected. To maintain resolution flexibility with the EEG, an overlap of 3.75 seconds was chosen.
EMG: In the case of the EMG signal, the main concern is the signal amplitude and the temporal resolution, not the actual frequencies. As no relevant low frequency content is expected, a segment length of 0.4 seconds and an overlap of 0.25 seconds was selected.
Scaling: As with the octave decomposition, the data is scaled, although only within segments:
where is the scaled correlation function and is the unscaled correlation function.
Architectures of CNN models used
The architecture of a CNN reflects the complexity of the problem that is being solved and how much training data is available, as a complex model has more parameters than a simple model, and is therefore more likely to over-fit. Much of this may, however, be solved using proper regularization. Another restriction is the resources required to train a model -the deep and complex models require more operations, take longer to train and operate. In this project no exhaustive hyper-parameter optimization was carried out. The architectures used were chosen on the basis of other published models, as described in Simonyan 2015 37 . Since the models utilize three separate modalities, three separate sub-networks are constructed. These are followed by fully connected layers combining the inputs from each sub-network, which are passed onto a softmax output (Figure 2b, Supplementary Figure 2) . Models utilizing memory have fully connected hidden units replaced with LSTM cells and recurrent connections added between successive segments. Networks of two different sizes are evaluated to quantify the effect of increasing complexity.
Training of CNN models
Training the models involves optimizing parameters to minimize a loss function evaluated across a training dataset. The loss function was defined as the cross-entropy with L2 regularization:
where is the true class label of the i th window, y ı � is the estimated probability of the i th window, is the parameter to be updated, and is the weight decay parameter set at 0.00001. The model parameters were initialized with (0,0.01), and trained until convergence using stochastic gradient decent with momentum 38 . Weight updates were done as: +1 = + +1 with +1 = − where α is the momentum set at 0.9, is the learning velocity, initialized at 0, and η is the learning rate, initially set at 0.005. The learning rate was gradually reduced with an exponential decay = 0 • − / where t is the number of updates and is a time constant, here set to 12,000.
Over-fitting was avoided using a number of regularization techniques, including batch normalization 39 , weight decay 40 , and early stopping 41 . Early stopping is accomplished by scheduling validation after every 50 th training batch. This is done by setting aside 10% of the training data. Training is stopped if the validation accuracy starts to decrease, as a sign of overfitting. For LSTM networks, dropout 42 was included, set at 0.5 while training. This ensured that model parameters generalized to the validation data and beyond. During training, data-batches were selected at random. Given the stochastic nature of the training procedure, it was likely that two realizations of the same model would not lead to the same results, since models end up in different local minima. To measure the effect of this, two realizations were made of each model.
Neural networks are essentially large ensembles of small models, consisting of individual perceptrons 43 . Thus, the outputs of more networks could be combined prior to the softmax layer, as this essentially expands the network. This property is further enhanced by the fact that each model has seen the training data in different amounts, a technique also used in bagging models e.g. random forest 44 . Several different ensembles were tested, as described in supplementary table 2.
Performance comparisons of generated CNN models
The influences of many different factors were analyzed. These included: using octave or CC decomposition, short (5 s) or long (15 s) windows lengths, low or high complexity, with or without LSTM, and using a single or two realizations of a model. To quantify the effect of each, a 2 5 -factorial experiment was designed. This lead to 32 different models (supplementary table 2). Model performance comparison was done on a per epoch basis.
Diagnostic Value of Sleep Stage Probability Distributions for the diagnosis of Type-1 Narcolepsy
The neural networks produce outputs that depend on evidence in the input data for or against a certain stage, based on features learned through training. We hypothesized that narcolepsy, a condition characterized by sleep/wake stage mixing/dissociation [45] [46] [47] [48] [49] would result in a greater than normal overlap between stages, an observation that was obvious when sleep stage probability were plotted in such subjects (Supplementary Figure 4) . Based on this result, we hypothesized that such an output could be used as a biomarker for the diagnosis of narcolepsy using a standard nocturnal PSG rather than the MSLT. A narcolepsy biomarker may also be generated as a direct output from the neural network, but by first generating an hypnodensity graph, or fuzzy hypnogram, a concept more familiar in the field, and extracting relevant features, the diagnostic reasoning becomes more transparent (also addressed in section: Future Work). To quantify narcolepsylike behavior, features were generated based on the product of every combination of the 5 stages:
where stages are one of 31 combinations, e.g. {Wake, N1}, {N1, N2, N3} etc. as shown in supplementary table 5 . is the predicted probability of a stage belonging to a certain class, given the data x. For every combination of stages, fifteen features based on the mean, derivative, entropy and cumulative sum were extracted, as shown in supplementary table 6. To avoid overfitting, and at the same time produce interpretable results, a recursive feature elimination algorithm was employed, as described in Guyon 2002 50 . Post-screening, the most optimal features were used in a Gaussian process classifier.
Additional features for Narcolepsy Diagnosis
One set of such features was selected because they have been found to differentiate Type-1 narcolepsy from other subjects in prior studies [51] [52] [53] [54] [55] [56] . These include: nocturnal sleep REM latency 13 , presence of a nightly SOREMP (REML ≤15 minutes) 13 , presence and number of SOREMPs during the night (SOREMPs defined as REM sleep occurring after at least 2.5 minutes of wake or stage 1), nocturnal sleep latency (a short sleep latency is common in narcolepsy) 51 . Other features include a NREM Fragmentation index described in Christensen et al. 51 (N2 and N3 combined to represent unambiguous NREM and N1 and wake combined to denote wake, NREM fragmentation defined as 22 or more occurrences where sustained N2/N3 (90 seconds) is broken by at least 1 minute of N1/Wake), and the number of W/N1 hypnogram bouts as defined by Christensen et al. 51 (N1 and wake combined to indicate wakefulness and a long period defined as 3 minutes or more) In this study we also explore: the cumulative wake/N1 duration for wakefulness periods shorter than 15 minutes; Cumulative REM duration following wake/N1 periods longer than 2.5 minutes; and total nightly SOREMP duration defined as the sum of REM epochs following 2.5 minutes W/N1 periods.
Another set of 9 features reflecting hypnodensity sleep stage distribution was also created as follows. As noted in supplementary figure 5 stages of sleep accumulate, forming peaks. These peaks were then used to create 9 new features based on the order of the peaks, expressing a type of transition (W to N2, W to REM, REM to N3 etc.). These were calculated as the geometric mean between the two peaks:
Due to their likeness, W and N1 peaks were added to form a single type. All transitions of a certain type were added together to form a single feature. A lower limit of 10 was imposed on peaks to avoid spuriosity. If two peaks of the same type appeared in succession the values were combined into a single peak.
HLA-DQB1*06:02 testing HLA testing plays a role in Type-1 narcolepsy diagnosis, as 97% of subjects are HLA-DQB1*06:02 when the disease is defined biochemically by low CSF hypocretin 6 or by the presence of cataplexy and clear MSLT findings 7, 13 . As testing for HLA-DQB1*06:02 only requires a single blood test, models in which this feature was included were also tested.
High pretest probability sample MSLT are typically performed in patients with daytime sleepiness that cannot be explained by obstructive sleep apnea, insufficient/disturbed sleep or circadian disturbances. These patients have a higher pretest probability of having type-1 narcolepsy than random clinical patients. Patients are then diagnosed with type-1 or type-2 narcolepsy, idiopathic hypersomnia or subjective sleepiness based on MSLT results, cataplexy symptoms, and HLA results (if available). To test whether our detector differentiates type-1 narcolepsy from these other cases with unexplained sleepiness, we therefore conducted a post hoc analysis of the detector performance in these subjects in the test dataset.
Gaussian Process Models for Narcolepsy Diagnosis
Gaussian process (GP) classifiers are non-parametric probabilistic models that produce robust non-linear decision boundaries using kernels, and unlike many other classification tools, provide an estimate of the uncertainty. This is useful when combining estimates, but also when making a diagnosis; if an estimate is particularly uncertain, a doctor may opt for more tests to increase certainty before making a diagnosis. In a GP, a training set is used to optimize a set of hyperparameters, which specify the kernel function, the basis function coefficients, here a constant, noise variance, and to form the underlying covariance and mean function from which inference about new cases are made 57 . In this case, the kernel is the squared exponential:
Two classes were established -narcolepsy type-1 and "other", which contains every other subject. These were labelled 1 and -1 respectively, placing all estimates in this range. Figure 1c provides a schematic overview of how the narcolepsy biomarker is created.
Code availability
All available code has been deposited in a GitHub repository named "github.com/Stanford-STAGES". A web based narcolepsy detector is being constructed on the trained model, where an European Data Format (EDF) file would be uploaded as the input and type-1 narcolepsy diagnosis provided as an output prediction. Table 2 displays overall reliability and individual consensus, when compared to the majority vote. In the event of a no majority vote, the epoch was split among classes with which there was disagreement. Only epochs scored by all 6 scorers were included. The final gold standard was the majority vote, weighted by the degree of consensus from each voter, expressed as its Cohen's Kappa,
Results
Inter-Scorer Reliability Results
, where is the baseline accuracy and is the scorer accuracy. This meant that scorers with a higher consensus with the group, who are thus considered more reliable, have their assessments weigh heavier. This also avoided split decisions on end-results.
Supplementary table 3 displays the confusion matrix for every epoch of every scorer of the interscorer reliability data, both un-adjusted (top) and adjusted (bottom). As in Rosenberg et al. 20 , the biggest disagreements occur between N1 and Wake, N1 and N2, and N2 and N3, with some errors also occurring between N1 and REM, and N2 and REM.
Model performance
Model accuracy varies across datasets, as scorer performance may be different across sites, and because unusual subjects can be more difficult to score -a problem affecting both human and machine scoring. In this study, the worst performance was achieved in the KHC and SSC with narcolepsy, and the best performance was achieved on IS-RC data (Figure 3a, Table 2 ). The SSC+KHC cohorts mainly contain patients with more fragmented sleeping patterns, which would explain a reduced performance. The IS-RC has the most accurate label, minimizing the effects of erroneous scoring, which therefore leads to an increased performance. Incorporating large ensembles of different models increased mean performance slightly ( Table 2 ). The two most important factors in producing accurate predictions were encoding and memory, while segment length, complexity and number of realizations were less important (Figure 3a) . The effect of encoding was less prominent in the IS-RC. Prominent factor interactions include (Supplementary Figure 3) : (i) CC models improve with higher complexity, whereas octave models worsen. (ii) Increasing segment length positively affects models with low complexity, but does not affect models with a high complexity. (iii) Adding memory improves models with an octave encoding more than models with a CC encoding. Because the IS-RC data is considered the most reliable, we decided to use this data as benchmark for model comparison. This standard improved as more scorers were added, and the model performance increased. (Figure 4a ). The different model configurations described in this section do not represent exhaustive configuration search, and future work experiments might result in improved results.
Concordance is presented in a weighted and un-weighted manner, between the best model estimate -the ensemble of all models, and scorer consensus (table: 3b). Weighing of a segment was based on scorer confidence and serves to down-weigh controversial segments. It was calculated as:
Where #2 ( ( | ) ) is the second most likely stage assessed by scorers of the i th epoch in a sleep recording. As with scorers, the biggest discrepancies occurred between wake versus N1, N1 versus N2 and N2 versus N3. Additionally, the weighted performance was almost universally better than the un-weighted performance, raising overall accuracy from 0.87 to 0.94, indicating a high consensus between automatic scoring and scorers in places with high scorer-confidence. An explanation for these results could be that both scorers and model are forced to make a choice between two stages when data is ambiguous. An example of this may be seen in Figure 5a . Between hours 1 and 3 several bouts of N3 occur, although they often do not reach the threshold for being the most likely stage. As time progresses, more evidence for N3 appears, reflecting increased proportion of slow waves per epoch, and confidence increases, finally yielding "definitive" N3. This is seen in both model and scorer estimates. Choosing to present the data as hypnodensity graphs mitigates this problem. The various model estimates produce similar results, which also resemble the scorer assessment distribution, although models without memory fluctuate slightly more, and tend to place a higher probability on REM sleep in periods of wakefulness, since no contextual information is provided.
Influences of Pathologies
As seen in table 2, the different cohorts achieve different performances. To see how much may be attributed to various pathologies, five different ANOVAs were made, with accuracy as the dependent variable, using cohort, age (grouped as age<30, 30≤age<50 and age≥50) and sex as covariates (supplementary , respectively. Cohort effects were expected and likely reflect local scorer performances and differences in PSG hardware and filter setups at every site. Decreased performance with age likely reflects decreased EEG amplitude, notably in N3/ slow wave sleep amplitude with age 58 .
Resolution of Sleep Stage scoring
As stated, epochs are generally evaluated with a resolution of 30 seconds, a standard that is not founded in anything physiological, which also limits the analytical possibilities in a hypnogram. Consequently, it was examined to what extend the performance would decrease as a smaller resolution was incorporated. To measure this, only the models using a segment size of 5 seconds were considered. Segments were averaged to achieve performances at 5, 10, 15 and 30 second resolutions (Figure 4b ).
Final Implementation of our optimized automatic Sleep Scoring algorithm
Because of model noise, potential inaccuracies, and the desire to quantify uncertainty, the final implementation is an ensemble of different CC models with small variations in model parameters, such as the number of feature-maps and hidden nodes. This is achieved by randomly varying the hyperparameters between 50% and 150% of the original values, using the CC/SH/LS/LSTM as a template, since this model achieved similar performance to the CC/LH/LS/LSTM while requiring significantly less computation power. All models make errors, but if errors occur independently of each other, the risk of not detecting and correcting falls. Thus, 16 such models are trained. At each analyzed segment, both mean and variance of the model estimates are calculated. The relative model variance (standardized to the average variance in a correct wakefulness prediction), is generally lower in correct predictions (supplementary table 4) . This informs users about uncertain/incorrect estimates. To demonstrate the effectiveness of this final implementation, the average of the models is shown alongside the distribution of 5234±14 scorers on 150 epochs, a data set provided by the AASM. On these epochs, the AASM ISR achieved a 0.90 agreement. In comparison, the model estimates reached a 0.95 accuracy compared to the AASM consensus (Figure 5b) .
Narcolepsy Biomarker evaluation
As demonstrated (Figure 3a, Table 2) , the CC models were most reliable, especially in subjects with narcolepsy. Therefore, these were the only models considered in this section. The average outcome of the RFE feature selection puts the optimal number of relevant features at 38. These are described in Supplementary Table 9 . A more detailed description can be found in Table 5 for the most important features. The optimal selection frequency cut-off of 0.40 (i.e. a feature was included 40% of the time) was determined using a cross-validation setup on the training data.
Final predictions are made by averaging predictions made by the 16 different models, achieved by creating a separate GP narcolepsy classifier from each of the sleep scoring models used in the final implementation. A cut-off threshold between narcolepsy type-1 and "other" was set at -0.03, determined using the training data, as shown in Figure 6a . The optimal trade-off achieves both high sensitivity and specificity, which is seen to translate well onto the test data (Figure 6b ). In the training data a sensitivity of 0.94 and a specificity of 0.96 were achieved, and in the testing data a sensitivity of 0.91 and a specificity of 0.96 were achieved. When HLA was added to this model (Figure 6c) , the sensitivity became 0.90 and the specificity rose to 0.99. More descriptive statistics are found in Table 6 .
Discussion
In recent years, machine learning has been used to solve similar or more complex problems, such as labeling images, understanding speech, and translating language, and have seen advancement to the point where humans are now sometimes outperformed 59, 25 . Automatic classification of sleep stages using automatic algorithms is not novel 20, 60, 61 , but only recently has this type of machine learning been applied and the effectiveness was only demonstrated in a small numbers of sleep studies [62] [63] [64] [65] . Because PSGs contain large amounts of manually annotated "gold standard" data, we hypothesized this method would be ideal to automatize sleep scoring. We show that machine learning can be used to score sleep stages in PSGs with high accuracy in multiple physical locations in various recording environments, using different protocols and hardware/software configurations, and in subjects with and without various sleep disorders.
After testing various machine learning algorithms with and without memory and specific encodings, we found increased robustness using a consensus of multiple algorithms in our prediction. The main reason for this is likely the sensitivity of each algorithm to particular aspects of each individual recording, resulting in increased or decreased predictability. Figure 3b displays the correlations between different models. Models that incorporate an ensemble of different models generally have a higher overall correlation coefficient than singular models, and since individual models achieve similar performances, it stands to reason that these would achieve the highest performance. One potential source for this variability was the fact recordings were conducted in different laboratories that were using different hardware and filters, and had PSGs scored by technicians of various abilities, in addition to the stochastic nature of the training. Another contributor was the presence of sleep pathologies in the dataset that could influence machine learning. Of the pathologies tested, only narcolepsy had very significant effect on the correspondence between manual and machine learning was narcolepsy (p=5x10 -22 vs 0.05 for sleep apnea for example) (Supplementary Table 7 and 8) . This was not surprising as the pathology is characterized by unusual sleep stage transitions, for example transitions from wake to REM sleep, which may make human or machine learning staging more difficult. This result suggests that reporting inter-model variations in accuracy for each specific patient has value in flagging unusual sleep pathologies, so that this metric is also reported by our detector.
Unlike previous attempts using automatic detector validations, we were also able to use 70 subjects scored by 6 different technicians in different laboratories (the IS-RC cohort) to independently validate our best automatic scoring consensus algorithm. This allowed us to estimate the performance at 0.87 in comparison to the performance of a consensus score for every epoch amongst six expert technicians (ultimate gold standard) ( Table 2) . Including more scorers produces a better gold standard, and as Figure 4a indicates, the model accuracy also increases with more scorers. Naturally, extrapolating from this should be done with caution, however, it is reasonable to assume that the accuracy would continue to increase with increased scorers. In comparison, performance of any individual scorer range from 0.77 to 0.86 when compared to the same 6 scorer gold standard, keeping in mind this performance is artificially inflated since the same scorers evaluated are included in the gold standard (unbiased performance of any scorer versus consensus of all the other 5 scorers range from 0.70-0.82. The best model achieves 0.85 using 5 scorers (Figure 4a) (Table 1) , indicating superiority to the best scorer. As with human scorers, the biggest discrepancies in machine learning determination of sleep stages occurred between wake versus N1, N1 versus N2 and N2 versus N3. This is logical as these particular sleep stage transitions are part of a continuum, artificially defined and subjective, for example an epoch comprised of 28 % slow wave activity is considered N2 while an epoch comprised of 30% slow wave activity qualifies as N3. Overall, data indicate that our machine learning algorithm performs better than individual scorers, as typically used in clinical practice, or similar to the best of 5 scorers in comparison to a combination of 5 experts scoring each epoch by consensus.
Using our models, and considering how atypical type-1 narcolepsy behaved in our sleep stage machine learning routines, we next extracted features that could be useful to diagnose this condition. Type-1 narcolepsy is characterized by the autoimmune loss of hypocretin-producing cells in the hypothalamus 3, 4 and can be best diagnosed by measuring hypocretin levels in the Cerebrospinal fluid (CSF) 14 , a procedure that requires a lumbar puncture, a rarely performed procedure in the US. At the symptomatic level, type-1 narcolepsy is characterized by sleepiness, cataplexy (episodes of muscle weakness during wakefulness triggered by emotions) and numerous symptoms reflecting poor nocturnal sleep (insomnia) and symptoms of "dissociated REM sleep", reflecting artificial states of consciousness where REM sleep is intermingled with wakefulness, producing disturbing reports of dreams that interrupt wakefulness and seem real (Dream-like hallucinations), or episodes where the sleeper is awake but paralyzed as in normal REM sleep (sleep paralysis). The current gold standard for type-1 narcolepsy diagnosis is the presence of cataplexy and positivity for the Multiple Sleep latency test (MSLT). In a recent large study of the MSLT, specificity and sensitivity for type-1 narcolepsy deficiency were, respectively, 98.6% and 92.9% in comparing type-1 narcolepsy versus controls and 71.2% and 93.4% in comparing type-1 narcolepsy versus other hypersomnia cases (high pre-test probability cohort) 13 . Table 5 and Supplementary Table 9 reveal features found in nocturnal PSGs that discriminate type-1 narcoleptics and non-narcoleptics. One of the most prominent features, nightly SOREMPs, bares great resemblance to the REM latency, which is already used clinically to diagnose narcolepsy, although in this case it is calculated using fuzzy logic and thus represent a latency where accumulated sleep is suggestive of a high probability of REM sleep having occurred (as opposed to a discrete REM latency scored by a technician). A short REM latency during nocturnal PSG (typically 15 minutes) has recently been shown to be extremely specific (99%) and moderately sensitive (40-50%) for type-1 narcolepsy 13, 66, 67 . The remaining selected features also describe a generally altered sleep architecture, particularly between REM sleep, light sleep and wake, aspects of narcolepsy already known and thus reinforcing their validity as biomarkers. Using these features, we were able to determine an optimal cut off that discriminated narcolepsy from controls and any other patients as high specificity and sensitivity as the MSLT (table 6), notably when HLA typing is added. The value of the detector was also tested in the context of patients with hypersomnia, and performance found to be superior to the MSLT.
MSLT testing requires that patients spend an entire night and day in a sleep laboratory. The use of this novel biomarker will reduce time spent to a standard 8-hour night recording, as done for the screening of other sleep pathologies (e.g. sleep apnea), allowing improved recognition of narcolepsy cases at a fraction of the cost. A positive predictive value could also be provided depending of the nature of the sample and known narcolepsy prevalence (low in general population screening, intermediary in overall clinic population sample, and high in hypersomnia cohorts). It also opens the possibility of using home sleep recordings for diagnosing narcolepsy. In this direction, because of the probabilistic and automatic nature of our biomarker, estimates from more than one night could be automatically analyzed and combined over time, ensuring improved prediction.
Conclusion and Future work
Models, which classify sleep by assigning a membership function to each of five different stages of sleep for each analyzed segment were produced, and factors contributing to the performance were analyzed. The models were evaluated on different cohorts, one of which contained 70 subjects scored by six different sleep scoring technicians, allowing for interscorer reliability assessments. The most successful model, consisting of an ensemble of different models, achieved an accuracy of 0.87, compared to an interscorer reliability on the same cohort of 0.81. When predictions were weighted by the scorer agreement, performance rose to 0.95, indicating a high consensus between the model and human scorers in areas of high scorer agreement. A final implementation was made using an ensemble with small variations of the best single model. This allowed for better predictions, while also providing a measure of uncertainty in an estimate.
When the staging data was presented as hypnodensity distributions, i.e. hypnograms in which a discrete value had not been assigned, the model conveyed more information about the subject than through a hypnogram alone. This led to the creation of a biomarker for narcolepsy that achieved similar performance to the current clinical gold standard, the MSLT but only requires a single sleep study. If increased specificity is needed, for example in large-scale screening, HLA or additional genetic typing brings specificity above 99% without loss of sensitivity. This presents an option for robust, consistent, inexpensive and simpler diagnosis of subjects who may have narcolepsy, as such tests may also be carried out in a home environment.
This study shows how hypnodensity graphs can be created automatically from raw sleep study data, and how the resulting interpretable features can be used to generate a diagnosis probability for type-1 narcolepsy. Another approach would be to classify narcolepsy directly from the neural network by optimizing the performance not only for sleep staging, but also for direct diagnosis by adding an additional softmax output, thereby creating a multitask classifier. This approach could lead to better predictions, since features are not then limited to by a designer imagination. A negative of this approach is that features would no longer be as interpretable and meaningful for clinicians. If meaning could be extracted from these neural network generated features, this might open the door to a single universal sleep analysis model, covering multiple diseases. Development of such a model would require adding more subjects with narcolepsy and other conditions to the pool of training data.
FIGURE LEGENDS
Fig 1a
Pre-processing steps taken to achieve the format of data as it is used in the neural networks. One of the 5 channels is first high-pass filtered with a cut-off at 0.2 Hz, then low-pass filtered with a cut-off at 49 Hz followed by a re-sampling to 100 Hz to ensure data homogeneity. In the case of EEG signals, a channel selection is employed to choose the channel with the least noise. The data is then encoded using either the CC or the octave encoding.
Fig 1b
Steps taken to produce and test the automatic scoring algorithm. A part of the SSC and WSC is randomly selected, as described in supplementary table 1. This data is then segmented in 5 minute segments and scrambled with segments from other subjects to increase batch similarity during training. A neural network is then trained until convergence (evaluated using a separate validation sample). Once trained, the networks are tested on a separate part of the SSC and WSC along with data from the IS-RC and KHC.
Fig 1c
Steps taken to produce and test the narcolepsy detector. Hypnodensities are extracted from data, as described in supplementary table 1. This data is separated into a training (60%) and a testing (40%) split. From the training split, 481 potentially relevant features, as described in supplementary table 6, are extracted from each hypnodensity. The prominent features are maintained using a recursive selection algorithm, and from these features a Gaussian process classifier is created. From the testing split, the same relevant features are extracted, and the Gaussian process classifier is evaluated.
Fig 2a
An example of the octave and the CC encoding on 10 seconds of EEG, EOG and EMG data. This processed data is fed into the neural networks in one of the two formats. The data in the octave encoding is offset for visualization purposes.
Fig 2b
Simplified network configuration, displaying how data is fed and processed through the networks. A more detailed description can be found in supplementary Figure 2 .
Fig 3a
Comparisons of the effect on accuracy by each factor at different settings on IS-RC data, SSC and KHC narcolepsy subjects, and the remaining SSC, KHC and WSC subjects used for testing.
Fig 3b
Correlation matrix showing similarities in different model predictions. Models 1-32 are single models, and 33-41 are ensembles. The models vary on 5 parameters, each at two levels, in the following order: Memory -FF or LSTM(1), segment size -5 s or 15 s (2), complexity -high or low (3), encoding -CC or octave (4), realizations -1 or 2 (5). Ensembles are as described in supplementary table 2: All FF octave models (33) , all LSTM octave models (34) , all FF CC models (35) , all LSTM CC models (36) , all FF models (37) , all LSTM models (38), all CC models (39) , all octave models (40), all models (41).
Fig 4a
The effect on scoring accuracy as golden standard is improved. Every combination of N scorers is evaluated in an unweighted manner and the mean is calculated. Accuracy is shown with mean and a 95% confidence interval.
Fig 4b
Predictive performance of best model at different resolutions. Performance is shown as mean accuracy with a 95% confidence interval.
Fig 5a
An example of a subject evaluated by multiple scorers (top) as well as different predictive models. The figure displays an hypnodensity graph, that is, a hypnogram in which a discrete value is not assigned to an epoch. Displayed models are, in order: Multiple scorer assessment (1); ensembles as described in supplementary table 2: All models, those with memory (LSTM) and those without memory (FF) (2-4); single models, as described in supplementary table 2 (5-7).
Color codes: White -wake, red -N1, light blue -N2, dark blue -N3, black -REM.
Fig 5b
150 epochs of a recording from the AASM ISR program are analyzed by 16 models with randomly varying parameters, using the CC/SH/LS/LSTM model as a template. This data was also evaluated by 5234±14 different scorers. The distribution of these is shown on top, the average model predictions are shown middle, and the model variance is shown at the bottom. Fig  6a,b,c Receiver operating charateristics (ROC) curves, displaying the trade-offs between sensitivity and specificity in the narcolepsy biomarker, shown for both training, and testing models, both with and without HLA included. The red dot displays the selected cut-off threshold of -0.04. Accuracy is presented as both with (first row) and without (second row) the assessed scorer included in the consensus standard in a leave-one-out fashion. All comparisons are on a by-epoch-basis. The targets are: Top row -un-weighted consensus. Bottom row -weighted by the scorer agreement at each epoch. The number of analyzed epochs were 53009 (un-weighted) and 36032 (weighted). The top row in every cell displays the un-weighed consensus, and the bottom row displays the weighed consensus. The values in the diagonal indicate a match between scorer and consensus. The total number of scored epochs were 324,978 
0.82
The time taken before 50% of the wakefulness in a recording has accumulated, weighed by the total amount of wakefulness.
The Shannon entropy of the REM sleep stage distribution. This expresses the amount of information held in a signal, or in this case, how many different values the REM sleep stage distribution obtainshow consolidated phases of REM are when the stage appears.
5
0.68
The maximum probability of wakefulness obtained in a recording.
The maximum value obtained of the product between the N2 and REM probability in a recording.
7
0.68
The time taken before 30% of the sum of the product between W and N2, calculated at every epoch, has accumulated, weighed by the total amount of this sum.
The time taken before 10% of the sum of the product between W and N1, calculated at every epoch, has accumulated, weighed by the total amount of this sum. with white blocks require multiplications and adding, whereas grey blocks are pooling or concatenations, default being max pooling. The top row of each block describes the size of the window and its stride, and the bottom row describes the size of the output. In this output, N is the length of a sequence, the second dimension is the segment length, and if a fourth dimension is present (CC models), the third dimension originally represents the size of the correlation function. The last dimension is the number of features in that layer. Models with a low complexity skip the third max pooling block, and go straight to mean pooling.
Supplementary Figure 3:
Interaction between different factors on the IS-RC data, and their effect on accuracy. The solid and dashed lines indicate factors along the rows on levels 1 and 2, respectively.
Supplementary Figure 4:
Probability distribution per stage of sleep for a subject without narcolepsy (top) and a subject with narcolepsy. The figure displays a hypnodensity, that is, a hypnogram in which a discrete value is not assigned to an epoch Color codes: White -wake, red -N1, light blue -N2, dark blue -N3, black -REM.
.
Supplementary Figure 5:
Peak cumulation plot, explaining how hypnodensity bout derived features are calculated.
Supplementary The top row in every cell displays the un-weighed consensus, and the bottom row displays the weighed consensus. The values in the diagonal indicate a match between scorer and consensus. The total number of scored epochs were 324,978 The top row of each cell is data from non-narcoleptics, the second row is from narcoleptics, and the bottom row is the p-value, indicating whether there is a significant difference in the two means. 98 narcolepsy subjects and 500 non-narcolepsy subjects were used for the analysis. 
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